Senators to FTC: Don't let the big Celgene and Allergan buyouts hurt R&D and consumers
The pharmaceutical industry has been merging like Porsches on the Autobahn of late, raising concerns from unions and consumer groups that a growing oligopoly is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
